Magnet Biomedicine’s modular platform enables the systematic discovery of true molecular glues towards the treatment of human disease. Our technology builds upon the discoveries of our Scientific Founders, who provided the seminal observations of molecular glues and have explored them for over 30 years.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $50M
Investors 2
| Date | Name | Website |
| 08.11.2023 | ARCH Ventu... | archventur... |
| - | Newpath Ma... | newpath.pa... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 19.09.2023 | - | $50M | - |
Mentions in press and media 1
| Date | Title | Description |
| 19.09.2023 | Magnet Biomedicine Raises $50M in Funding | Magnet Biomedicine, a Cambridge, MA-based biotechnology company advancing molecular glue discovery with rational selection and design, raised $50M in funding. The round was led by Newpath Partners, and ARCH Venture Partners. The company int... |